Mingu Gordon Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mingu Gordon Park has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Changjoon Justin Lee
Institute for Basic Sciences
2 shared publications - Byeoung-Kyu Choi
Department of Bio-Convergence Engineering, Dongyang Mirae University, Seoul 08221, Republic of Korea
1 shared publication - Hee Jae Shin
Marine Natural Products Chemistry Laboratory, Korea Institute of Ocean Science and Technology, 385 Haeyang-ro, Yeongdo-gu, Busan 49111, Republic of Korea
1 shared publication - Min-Ho Nam
Center for Brain Disorders, Brain Science Institute, Korea Institute of Science and Technology, Seoul, Republic of Korea
1 shared publication - Moonsun Sa
Center for Cognition and Sociality, Institute for Basic Science, Daejeon, Republic of Korea
1 shared publication - Myeongju Kim
Center for Memory and Glioscience, Institute for Basic Science, Daejeon 34126, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 5 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (10) , 1293
K34 (3,3″-Dihydroxy-6′-desmethyl Terphenyllin) Promotes Hemoglobin-Supported H2O2 Decomposition and Attenuates Neurodegenerative Phenotypes in APP/PS1 Mice with Focal GiD
Hydrogen peroxide (H2O2) contributes to oxidative stress in Alzheimer’s disease (AD), yet conventional antioxidants that directly scavenge H2O2 have shown limited therapeutic efficacy. Here, we investigated K34 (3,3″-dihydroxy-6′-desmethyl terphenyllin), a catechol-bearing para-terphenyl isolated from the marine fungus Penicillium janthinellum 168CLC-17.1, as an indirect H2O2-decomposing agent. Complementary cell-free assays showed that K34 promoted peroxidase-dependent H2O2 decomposition, including Hb-supported H2O2 decomposition, while molecular docking predicted a plausible binding pose near the Hbβ heme pocket. In amyloid-β42 (Aβ42)-stimulated primary astrocytes, K34 reduced intracellular H2O2. In APPswe/PSEN1dE9 (APP/PS1) mice subjected to focal GFAP-inducible diphtheria toxin receptor (fGiD), systemic K34 attenuated memory impairment, preserved NeuN-positive neurons, reduced GFAP immunoreactivity, and improved hippocampal spike probability. K34 also exhibited low passive blood–brain barrier (BBB) permeability and limited inhibition of five major cytochrome P450 (CYP) isoforms under the tested conditions. These findings extend Hb-supported H2O2 decomposition to a structurally distinct marine natural product and support further evaluation of K34 as an antioxidant scaffold for modulating oxidative stress-associated neurodegenerative phenotypes.
- 5 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (10) , 1293
Open AccessK34 (3,3″-Dihydroxy-6′-desmethyl Terphenyllin) Promotes Hemoglobin-Supported H2O2 Decomposition and Attenuates Neurodegenerative Phenotypes in APP/PS1 Mice with Focal GiD
Hydrogen peroxide (H2O2) contributes to oxidative stress in Alzheimer’s disease (AD), yet conventional antioxidants that directly scavenge H2O2 have shown limited therapeutic efficacy. Here, we investigated K34 (3,3″-dihydroxy-6′-desmethyl terphenyllin), a catechol-bearing para-terphenyl isolated from the marine fungus Penicillium janthinellum 168CLC-17.1, as an indirect H2O2-decomposing agent. Complementary cell-free assays showed that K34 promoted peroxidase-dependent H2O2 decomposition, including Hb-supported H2O2 decomposition, while molecular docking predicted a plausible binding pose near the Hbβ heme pocket. In amyloid-β42 (Aβ42)-stimulated primary astrocytes, K34 reduced intracellular H2O2. In APPswe/PSEN1dE9 (APP/PS1) mice subjected to focal GFAP-inducible diphtheria toxin receptor (fGiD), systemic K34 attenuated memory impairment, preserved NeuN-positive neurons, reduced GFAP immunoreactivity, and improved hippocampal spike probability. K34 also exhibited low passive blood–brain barrier (BBB) permeability and limited inhibition of five major cytochrome P450 (CYP) isoforms under the tested conditions. These findings extend Hb-supported H2O2 decomposition to a structurally distinct marine natural product and support further evaluation of K34 as an antioxidant scaffold for modulating oxidative stress-associated neurodegenerative phenotypes.
- Open Access
- 18 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4453
Revisiting the Role of Astrocytic MAOB in Parkinson’s Disease
Monoamine oxidase-B (MAOB) has been believed to mediate the degradation of monoamine neurotransmitters such as dopamine. However, this traditional belief has been challenged by demonstrating that it is not MAOB but MAOA which mediates dopamine degradation. Instead, MAOB mediates the aberrant synthesis of GABA and hydrogen peroxide (H2O2) in reactive astrocytes of Parkinson’s disease (PD). Astrocytic GABA tonically suppresses the dopaminergic neuronal activity, whereas H2O2 aggravates astrocytic reactivity and dopaminergic neuronal death. Recently discovered reversible MAOB inhibitors reduce reactive astrogliosis and restore dopaminergic neuronal activity to alleviate PD symptoms in rodents. In this perspective, we redefine the role of MAOB for the aberrant suppression and deterioration of dopaminergic neurons through excessive GABA and H2O2 synthesis of reactive astrocytes in PD.
- 18 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (8) , 4453
Open AccessRevisiting the Role of Astrocytic MAOB in Parkinson’s Disease
Monoamine oxidase-B (MAOB) has been believed to mediate the degradation of monoamine neurotransmitters such as dopamine. However, this traditional belief has been challenged by demonstrating that it is not MAOB but MAOA which mediates dopamine degradation. Instead, MAOB mediates the aberrant synthesis of GABA and hydrogen peroxide (H2O2) in reactive astrocytes of Parkinson’s disease (PD). Astrocytic GABA tonically suppresses the dopaminergic neuronal activity, whereas H2O2 aggravates astrocytic reactivity and dopaminergic neuronal death. Recently discovered reversible MAOB inhibitors reduce reactive astrogliosis and restore dopaminergic neuronal activity to alleviate PD symptoms in rodents. In this perspective, we redefine the role of MAOB for the aberrant suppression and deterioration of dopaminergic neurons through excessive GABA and H2O2 synthesis of reactive astrocytes in PD.